Table 3.
Nodal region | UPCI | UMCU | ||||||
---|---|---|---|---|---|---|---|---|
D90 pLNN (Gy EQD2) | D90 pLNN (Gy EQD2) | |||||||
n | Mean | SD | Range | n | Mean | SD | Range | |
Common ililac | 4 | 1.6 | 0.2 | 1.4-2.5 | 1 | 5 | ||
Internal iliac | 14 | 2.4 | 0.8 | 1.3-6.6 | 11 | 4.7 | 2.3 | 2.2-8.7 |
External iliac | 32 | 2.8 | 1.4 | 1.3-6.0 | 18 | 6.2 | 2.9 | 2.7-12.0 |
Obturator | 7 | 3.4 | 2.2 | 1.7-5.7 | 5 | 5.3 | 1.1 | 3.7-6.3 |
Parametrial | 0 | 3 | 22.8 | 12.2 | 14.2-36.7 | |||
Inguinal | 0 | 1 | 5.1 | |||||
Perirectal | 0 | 1 | 13 |
UPCI – University of Pittsburgh Cancer Institute, UMCU – University Medical University Utrecht, pLNN – pathologically enlarged pelvic lymph-nodes, D90 – dose to 90% of the volume, EQD2 – biologically equivalent dose in 2-Gy fractions, SD – standard deviation